These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34760102)

  • 1. Mucinous cystadenocarcinoma of breast in a 69-year-old woman with positive hormone receptors, the first case reported.
    Kamrani G; Nikbakhsh N; Hosseini A; Ghorbani H; Arefisigaroudi N; Davarian A
    Caspian J Intern Med; 2021; 12(Suppl 2):S444-S446. PubMed ID: 34760102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucinous cystadenocarcinoma of the breast: the challenge of diagnosing a rare entity.
    Koufopoulos N; Goudeli C; Syrios J; Filopoulos E; Khaldi L
    Rare Tumors; 2017 Oct; 9(3):7016. PubMed ID: 29081926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed primary mucinous cystadenocarcinoma and invasive ductal carcinoma of the breast: a case report and literature review.
    Zuo C; Xie J
    Transl Cancer Res; 2022 Dec; 11(12):4455-4464. PubMed ID: 36644191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary Mucinous Cystadenocarcinoma of the Breast Intermixed with Pleomorphic Invasive Lobular Carcinoma: The First Report of This Rare Association.
    Vegni F; D'Alessandris N; Santoro A; Angelico G; Scaglione G; Carlino A; Arciuolo D; Valente M; Sfregola S; Natale M; Sanchez AM; Masciullo V; Zannoni GF; Mulè A
    J Pers Med; 2023 Jun; 13(6):. PubMed ID: 37373937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.
    Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K
    Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HER2-positive mucinous cystadenocarcinoma of the breast coexisting with invasive lobular carcinoma: A case report and review of the literature.
    Guzelis I; Kucukzeybek BB; Uyaroglu MA; Gokova MB; Sezgin G; Kucukzeybek Y
    Diagn Cytopathol; 2024 Sep; 52(9):E208-E214. PubMed ID: 38837688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucinous cystadenocarcinoma of the breast with a basal-like immunophenotype.
    Deng Y; Xue D; Wang X; Xu S; Ao Q; Hu Z; Wang G
    Pathol Int; 2012 Jun; 62(6):429-32. PubMed ID: 22612513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Her-2 positive mucinous carcinoma breast cancer, case report.
    Garcia Hernandez I; Canavati Marcos M; Garza Montemayor M; Lopez Sotomayor D; Pineda Ochoa D; Gomez Macias GS
    Int J Surg Case Rep; 2018; 42():242-246. PubMed ID: 29291541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of HER2/neu, estrogen and progesterone receptors, CA 125 and CA19-9 on cancer cell membrane in patients with serous and mucinous carcinoma of the ovary.
    Karaferic A; Jovanovic D; Jelic S
    J BUON; 2009; 14(4):635-9. PubMed ID: 20148455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammary synchronous mucinous cystadenocarcinoma and columnar cell mucinous carcinoma: a case report.
    Sun M; Su S; Liu Q; Li Q; Wang K
    Int J Clin Exp Pathol; 2020; 13(9):2381-2386. PubMed ID: 33042347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary mucinous cystadenocarcinoma of the breast with amplification of the HER2 gene confirmed by FISH - case report and review of the literature.
    Kucukzeybek BB; Yigit S; Sari AA; Rezanko T; Durak E; Sadullahoglu C
    Pol J Pathol; 2014 Mar; 65(1):70-3. PubMed ID: 25119013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucinous cystadenocarcinoma of the breast: a new entity with broad differentials-a case report.
    Kaur K; Shah A; Gandhi J; Trivedi P
    J Egypt Natl Canc Inst; 2022 Feb; 34(1):9. PubMed ID: 35224708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary mammary mucinous cystadenocarcinoma: cytological and histological findings.
    Sentani K; Tashiro T; Uraoka N; Aosaki Y; Yano S; Takaeko F; Yasui W
    Diagn Cytopathol; 2012 Jul; 40(7):624-8. PubMed ID: 21472867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary Mucinous Cystadenocarcinoma of the Breast: Clinicopathological Analysis of a Case and Difficulties Encountered in a Biopsy.
    Özşen M; Tolunay Ş; Gökgöz MŞ; Deligönül A
    Int J Surg Pathol; 2024 Sep; 32(6):1158-1164. PubMed ID: 38073094
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer.
    Park C; Park K; Kim J; Sin Y; Park I; Cho H; Yang K; Bae BN; Kim KW; Ahn S; Gwak G
    World J Surg Oncol; 2016 Sep; 14(1):244. PubMed ID: 27619909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibin expression in ovarian-type stroma in mucinous cystic neoplasms of the pancreas.
    Yeh MM; Tang LH; Wang S; Robert ME; Zheng W; Jain D
    Appl Immunohistochem Mol Morphol; 2004 Jun; 12(2):148-52. PubMed ID: 15354741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-Existing Ovarian Mucinous Cystadenocarcinoma with Mature Cystic Teratoma: A Rare Case Report.
    Suwannarurk K; Thaweekul Y; Mairaing K; Poomtavorn Y; Piyawong W; Himakhun W; Bhamarapravatana K
    J Med Assoc Thai; 2016 Jul; 99 Suppl 4():S281-6. PubMed ID: 29927186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary Breast Mucinous Cystadenocarcinoma and Review of Literature.
    Moatasim A; Mamoon N
    Cureus; 2022 Mar; 14(3):e23098. PubMed ID: 35464581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary Mucinous Cystadenocarcinoma of the Breast: Cytologic Finding and Expression of MUC5 Are Different from Mucinous Carcinoma.
    Kim SE; Park JH; Hong S; Koo JS; Jeong J; Jung WH
    Korean J Pathol; 2012 Dec; 46(6):611-6. PubMed ID: 23323116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.